We are live on ! Find out more
CCM

Carderock Capital Management Portfolio holdings

AUM $456M
1-Year Est. Return 31.89%
This Fund
S&P 500
This Quarter Est. Return
+12.05%
1 Year Est. Return
+31.89%
3 Year Est. Return
+88.65%
5 Year Est. Return
+111.4%
10 Year Est. Return
+513.53%
AUM
$362M
AUM Growth
+$64.2M
Cap. Flow
+$28.6M
Cap. Flow %
7.9%
Top 10 Hldgs %
31.1%
Holding
62
New
5
Increased
37
Reduced
16
Closed
1

Top Buys

Rank Stock Value
1
WST icon
West Pharmaceutical
WST
+$4.61M
2
STE icon
Steris
STE
+$4.13M
3
IDXX icon
Idexx Laboratories
IDXX
+$2.03M
4
ROP icon
Roper Technologies
ROP
+$1.78M
5
SPGI icon
S&P Global
SPGI
+$1.77M

Sector Composition

Rank Sector Weight
1 Technology 32.57%
2 Industrials 22.38%
3 Healthcare 13.49%
4 Financials 12.79%
5 Consumer Discretionary 5.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.54T
$14.9M 4.11%
77,263
-362
-0.5% -$66.8K
MA icon
2
Mastercard
MA
$502B
$13.5M 3.74%
31,748
+125
+0.4% +$50.2K
MSFT icon
3
Microsoft
MSFT
$3.45T
$12.9M 3.56%
34,330
+1,143
+3% +$407K
GOOGL icon
4
Alphabet (Google) Class A
GOOGL
$4.36T
$11M 3.03%
78,668
+5,666
+8% +$761K
PH icon
5
Parker-Hannifin
PH
$123B
$10.7M 2.95%
23,212
+3,220
+16% +$1.34M
CTAS icon
6
Cintas
CTAS
$81.9B
$10.5M 2.89%
69,552
+9,680
+16% +$1.3M
LRCX icon
7
Lam Research
LRCX
$367B
$10.3M 2.84%
131,480
+9,190
+8% +$626K
CDNS icon
8
Cadence Design Systems
CDNS
$93.6B
$10.1M 2.78%
37,002
+1,808
+5% +$466K
SPGI icon
9
S&P Global
SPGI
$121B
$9.66M 2.67%
21,936
+4,490
+26% +$1.77M
IDXX icon
10
Idexx Laboratories
IDXX
$44.1B
$9.11M 2.52%
16,416
+4,315
+36% +$2.03M
SHW icon
11
Sherwin-Williams
SHW
$82.7B
$8.87M 2.45%
28,423
+3,521
+14% +$947K
APH icon
12
Amphenol
APH
$198B
$8.77M 2.42%
176,974
+10,654
+6% +$471K
FTNT icon
13
Fortinet
FTNT
$119B
$8.72M 2.41%
149,048
+10,508
+8% +$581K
ROP icon
14
Roper Technologies
ROP
$38.8B
$8.65M 2.39%
15,862
+3,453
+28% +$1.78M
ITW icon
15
Illinois Tool Works
ITW
$82.6B
$8.47M 2.34%
32,343
-367
-1% -$87.9K
ACN icon
16
Accenture
ACN
$102B
$8.22M 2.27%
23,428
+1,084
+5% +$349K
AME icon
17
Ametek
AME
$55.4B
$8.07M 2.23%
48,946
+6,004
+14% +$915K
ORLY icon
18
O'Reilly Automotive
ORLY
$72.9B
$8.05M 2.22%
127,065
+1,200
+1% +$75.8K
ANSS
19
DELISTED
Ansys
ANSS
$7.62M 2.11%
21,007
+793
+4% +$235K
HON icon
20
Honeywell
HON
$77B
$7.58M 2.09%
38,374
+1,432
+4% +$258K
MCO icon
21
Moody's
MCO
$82.8B
$7.56M 2.09%
19,346
+4,983
+35% +$1.73M
AON icon
22
Aon
AON
$76.5B
$7.5M 2.07%
25,768
+462
+2% +$148K
PWR icon
23
Quanta Services
PWR
$100B
$7.44M 2.06%
34,495
+1,133
+3% +$209K
ADP icon
24
Automatic Data Processing
ADP
$106B
$7.44M 2.05%
31,914
+2,734
+9% +$637K
COST icon
25
Costco
COST
$422B
$7.34M 2.03%
11,114
-186
-2% -$110K

Similar funds

Carderock Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Carderock Capital Management held 62 positions worth $362M, up 22% from $298M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Carderock Capital Management deployed $28.6M of net new capital in Q4 2023, opening 5 new positions and adding to 37 existing holdings. Its largest new stake was West Pharmaceutical: 13,033 shares worth $4.59M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 33% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Pool Corp, an estimated $1.52M trimmed.

  • Carderock Capital Management's largest Q4 2023 buy was West Pharmaceutical: 13,033 shares worth $4.59M.
  • Carderock Capital Management added most to Idexx Laboratories in Q4 2023, an estimated $2.03M increase.
  • Carderock Capital Management's biggest Q4 2023 reduction was Pool Corp, cutting an estimated $1.52M.
  • Carderock Capital Management fully exited Enphase Energy in Q4 2023, selling an estimated $1.53M.
  • Carderock Capital Management's ten largest holdings make up 31% of its $362M portfolio in Q4 2023.
  • Carderock Capital Management opened 5 new positions and closed 1 in Q4 2023.
  • Carderock Capital Management's portfolio value rose 22% quarter-over-quarter to $362M.

Based on Carderock Capital Management's 13F filing for Q4 2023, filed 23 Jan 2024.